Smith, Moore & Co. Bristol Myers Squibb CO Transaction History

Smith, Moore & Co.

$1.03 Billion
Q3 2024

A detailed history of Smith, Moore & Co. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Smith, Moore & Co. holds 29,836 shares of BMY stock, worth $1.7 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares

29,836

Previous 30,093 0.85%

Holding current value

$1.7 Million

Previous $1.25 Million 23.62%

% of portfolio

0.15%

Previous 0.13%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$39.66 - $51.75 $10,192 - $13,299	-257 Reduced 0.85%	29,836 $1.54 Million
Q2 2024 Aug 14, 2024	SELL	$40.25 - $52.99 $82,915 - $109,159	-2,060 Reduced 6.41%	30,093 $1.25 Million
Q1 2024 May 10, 2024	SELL	$47.98 - $54.4 $41,118 - $46,620	-857 Reduced 2.6%	32,153 $1.74 Million
Q4 2023 Feb 13, 2024	SELL	$48.48 - $57.85 $1,018 - $1,214	-21 Reduced 0.06%	33,010 $1.69 Million
Q3 2023 Nov 14, 2023	SELL	$57.89 - $64.73 $9,378 - $10,486	-162 Reduced 0.49%	33,031 $1.92 Million
Q2 2023 Aug 11, 2023	BUY	$63.71 - $70.74 $67,341 - $74,772	1,057 Added 3.29%	33,193 $2.12 Million
Q1 2023 May 12, 2023	BUY	$65.71 - $74.53 $28,386 - $32,196	432 Added 1.36%	32,136 $2.23 Million
Q4 2022 Feb 13, 2023	SELL	$68.48 - $81.09 $38,074 - $45,086	-556 Reduced 1.72%	31,704 $2.28 Million
Q3 2022 Nov 14, 2022	SELL	$0.13 - $76.84 $83 - $49,254	-641 Reduced 1.95%	32,260 $2.29 Million
Q2 2022 Aug 12, 2022	SELL	$72.62 - $79.98 $121,057 - $133,326	-1,667 Reduced 4.82%	32,901 $2.53 Million
Q1 2022 May 12, 2022	SELL	$61.48 - $73.72 $3,565 - $4,275	-58 Reduced 0.17%	34,568 $2.52 Million
Q4 2021 Feb 08, 2022	BUY	$53.63 - $62.52 $67,037 - $78,150	1,250 Added 3.75%	34,626 $2.16 Million
Q3 2021 Nov 12, 2021	BUY	$59.17 - $69.31 $72,956 - $85,459	1,233 Added 3.84%	33,376 $1.98 Million
Q2 2021 Aug 10, 2021	SELL	$61.91 - $67.42 $19,068 - $20,765	-308 Reduced 0.95%	32,143 $2.21 Million
Q1 2021 May 14, 2021	BUY	$59.34 - $66.74 $662,946 - $745,619	11,172 Added 52.5%	32,451 $2.05 Million
Q4 2020 Feb 16, 2021	BUY	$57.74 - $65.43 $28,812 - $32,649	499 Added 2.4%	21,279 $1.26 Million
Q3 2020 Nov 12, 2020	BUY	$57.43 - $63.64 $223,574 - $247,750	3,893 Added 23.05%	20,780 $1.25 Million
Q2 2020 Aug 10, 2020	SELL	$54.82 - $64.09 $178,274 - $208,420	-3,252 Reduced 16.15%	16,887 $934,000
Q1 2020 May 15, 2020	BUY	$46.4 - $67.43 $42,316 - $61,496	912 Added 4.74%	20,139 $1.12 Million
Q4 2019 Feb 07, 2020	BUY	$49.21 - $64.19 $30,264 - $39,476	615 Added 3.3%	19,227 $1.23 Million
Q3 2019 Nov 07, 2019	SELL	$42.77 - $50.71 $80,835 - $95,841	-1,890 Reduced 9.22%	18,612 $944,000
Q2 2019 Aug 15, 2019	BUY	$44.62 - $49.34 $52,696 - $58,270	1,181 Added 6.11%	20,502 $929,000
Q1 2019 May 07, 2019	BUY	$45.12 - $53.8 $27,523 - $32,818	610 Added 3.26%	19,321 $970,000
Q4 2018 Feb 15, 2019	SELL	$48.76 - $63.23 $43,737 - $56,717	-897 Reduced 4.57%	18,711 $973,000
Q3 2018 Nov 15, 2018	BUY	$55.19 - $62.25 $29,857 - $33,677	541 Added 2.84%	19,608 $1.22 Million
Q2 2018 Aug 14, 2018	SELL	$50.53 - $62.98 $252 - $314	-5 Reduced 0.03%	19,067 $1.06 Million
Q1 2018 May 14, 2018	BUY	$59.92 - $68.98 $54,227 - $62,426	905 Added 4.98%	19,072 $1.21 Million
Q4 2017 Feb 09, 2018	SELL	$59.94 - $65.35 $28,231 - $30,779	-471 Reduced 2.53%	18,167 $1.11 Million
Q3 2017 Nov 02, 2017	BUY	$55.23 - $63.74 $1.03 Million - $1.19 Million	18,638	18,638 $1.19 Million

Others Institutions Holding BMY

# of Institutions

2,537

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $121B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Smith, Moore & Co., based on Form 13F filings with the SEC.

News

Stay updated on Smith, Moore & Co. with notifications on news.

Account